Apeiron Investment Group to bring 10 portfolio companies to UAE next year – The National

Apeiron Investment Group to bring 10 portfolio companies to UAE next year – The National

Apeiron Investment Group, the private investment company of billionaire investor Christian Angermayer, is looking for new investment opportunities in the UAE and plans to move as many as 10 portfolio companies to the Emirates next year to expand its presence in the region.The five to 10 companies that will have a “strong presence” in the Arab world’s second-largest economy will include several biotechnology firms, Mr Angermayer told The National on the sidelines of Abu Dhabi Finance Week.“We got to move several of our biotech companies here. We'll not just do an office here but do clinical studies, which will be groundbreaking because, to my knowledge, we are the first or one of the first to do so,” he said.Abu Dhabi has a strong focus on developing the biotech industry and it needs “specialised people” for the “high-intellect sectors” it aims to develop, he added.“We are very pleasantly surprised that Abu Dhabi has a great healthcare infrastructure, from universities with early stage science to hospitals which allow our biotech portfolio companies to do clinical research and drug development approval studies here on the ground,” Mr Angermayer said.Apeiron, with a biotech portfolio that includes Atai Life Science, Mubadala Investment Company-backed Rejuveron and